Overview

Impact of Switching to NNRTI-based Therapy on the Quality of Life of HIV-infected Patients With Virological Suppression

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Observational study to evaluate therapeutic switch to a NNRTI-based regimen on quality of life of HIV-positive patients
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Reverse Transcriptase Inhibitors